共 50 条
- [23] THE EFFECT OF 3 DOSE LEVELS OF ICS 205-930 (A SELECTIVE 5HT-3 ANTAGONIST) ON CISPLATIN-INDUCED NAUSEA AND VOMITING EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (09): : 1333 - 1335
- [24] 1ST RESULTS WITH ICS-205-930 (5-HT3 RECEPTOR ANTAGONIST) IN PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS LANCET, 1987, 1 (8543): : 1198 - 1198
- [25] A COMPARATIVE-STUDY OF THE USE OF NAVOBAN (ICS 205-930), A 5-HT3 ANTAGONIST, VERSUS A STANDARD ANTIEMETIC REGIMEN OF DEXAMETHASONE AND METOCLOPRAMIDE IN THE TREATMENT OF CISPLATIN-CONTAINING CHEMOTHERAPY DRUG INVESTIGATION, 1993, 6 (03): : 162 - 169
- [27] COMPETITIVE INTERACTION OF AGONISTS AND ANTAGONISTS WITH 5-HT3 RECOGNITION SITES IN MEMBRANES OF NEURO-BLASTOMA CELLS LABELED WITH [H-3] ICS 205-930 JOURNAL OF RECEPTOR RESEARCH, 1989, 9 (01): : 65 - 79
- [29] ENHANCEMENT OF MEMORY RETRIEVAL AND ATTENUATION OF SCOPOLAMINE-INDUCED AMNESIA FOLLOWING ADMINISTRATION OF 5-HT3 ANTAGONIST ICS-205-930 PHARMACOLOGY & TOXICOLOGY, 1991, 69 (02): : 105 - 106